Stifel Nicolaus is out with its report today on Sunrise Senior Living SRZ, downgrading SRZ from Buy to Hold.
In a note to clients, Stifel Nicolaus writes, "SRZ shares are essentially at our $12 target price and we are lowering our rating to Hold. We believe future upside remains in the shares if (1) longer term the company continues to improve occupancy and rate, improve its operating margins and lower G&A costs or (2) if Sunrise is purchased by another senior housing operator perhaps working together with a healthcare REIT."
At the time of posting, shares of SRZ were trading pre-market at $11.57, down 3.02% from Thursday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care FacilitiesStifel NicolausSunrise Senior Living
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in